Clinical trials in Luebeck – page 21

In Lübeck, a large share of clinical research focuses on cancer and blood disorders, with studies exploring new ways to improve survival, reduce recurrence, and strengthen treatment responses.

• Non-Small Cell Lung Cancer and Small Cell Lung Cancer
• Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Large B-Cell Lymphoma
• Melanoma, Prostate Cancer, and Breast Cancer
• Testing new immunotherapies, targeted treatments, and perioperative strategies

These trials aim to improve disease control in both solid tumors and hematologic malignancies, often comparing innovative combinations with current standard care.

Several trials examine immune-mediated diseases and skin conditions, reflecting strong interest in treatments that can reduce inflammation and improve daily comfort.

• Atopic Dermatitis, Plaque Psoriasis, and Hidradenitis Suppurativa
• Alopecia Areata and Chronic Spontaneous Urticaria
• Systemic Lupus Erythematosus and related inflammatory disorders
• Evaluating newer immune-modulating therapies and symptom relief

This area of research is centered on better long-term control of chronic symptoms while seeking treatments that are easier for patients to tolerate.

Clinical trials in neurology address urgent and chronic conditions, with a strong emphasis on recovery, safety, and functional outcomes.

• Acute Ischemic Stroke and high-risk transient ischemic events
• Amyotrophic Lateral Sclerosis and other progressive nervous system diseases
• Testing therapies that may improve recovery or slow neurological decline

Research in this field aims to support patients both in the acute phase of disease and across longer-term neurological care.

Studies in eye diseases focus on preserving vision and improving outcomes for conditions that can lead to lasting impairment.

• Uveitic Macular Edema
• Geographic Atrophy related to age-related macular degeneration
• Retinal artery occlusion and other sight-threatening retinal disorders

These trials are designed to assess whether new treatments can protect visual function or restore it after injury and inflammation.

Research in metabolic disease and cardiovascular health includes trials that look at blood sugar control, body weight, and major health risks.

• Type 2 Diabetes
• Obesity and Overweight
• Cardiovascular disease risk and related mortality outcomes
• Assessing medicines that may improve metabolic balance and long-term health

In Lübeck, this research reflects a broader effort to find therapies that support prevention as well as treatment.

Respiratory disease trials in the city explore both chronic airway inflammation and serious lung conditions that affect breathing and quality of life.

• Asthma, including eosinophilic and severe forms
• Idiopathic Pulmonary Fibrosis
• Chronic Rhinosinusitis without nasal polyps
• Testing therapies intended to ease symptoms and improve lung function

These studies are aimed at better control of persistent respiratory illness and more effective treatment options for difficult-to-manage disease.

There is also important work in digestive and liver disorders, with studies focused on advanced disease and improved treatment selection.

• Advanced Hepatocellular Carcinoma
• Alcohol-related liver disease
• Oligometastatic pancreatic cancer

These trials are examining new ways to extend survival, manage disease burden, and refine combined treatment approaches.

Renal research includes both kidney inflammation and severe kidney injury, with trials seeking better protection of kidney function.

• IgA Nephropathy
• Rapidly Progressive Glomerulonephritis
• End-stage renal disease or reduced kidney function

These studies aim to slow progression, reduce protein loss in the urine, and improve outcomes in patients at high risk of kidney failure.

Urologic oncology is another active area, with research centered on treatment effectiveness before and after surgery and on disease control in advanced cancer.

• Prostate Cancer, including metastatic and high-risk localized disease
• Bladder Cancer
• Male Urogenital Diseases and surgical treatment strategies

These trials are designed to improve survival and reduce the chance of recurrence in patients with complex urologic cancers.

Some studies in Lübeck focus on children and adolescents with rare cancers, where the goal is often to refine treatment while preserving long-term health.

• Malignant Extracranial Germ Cell Tumours
• Childhood renal tumors
• Mature aggressive B-cell lymphoma and leukemia
• Exploring safer and more effective therapy options for younger patients

These trials are especially important because they address conditions that are uncommon but medically demanding.

A smaller but notable part of the research portfolio involves vascular medicine and surgical care, with emphasis on urgent treatment decisions and recovery.

• Stroke-related emergency care
• Anticoagulation reversal before urgent procedures
• Operative and perioperative treatment strategies

These studies are intended to improve safety, speed, and effectiveness in time-sensitive clinical situations.